CTIC Overview
Upcoming Projects (CTIC)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (CTIC)
-
An Eighth Take: Looking at Momelotinib & Pacritinib in treating Myelofibrosis
Tickers: SRRA, CTIC
Executed On: Jan 21, 2022 at 10:05 AM EST -
A Seventh Take: Looking at Momelotinib & Pacritinib in treating Myelofibrosis
Tickers: SRRA, CTIC
Executed On: Jan 20, 2022 at 05:00 PM EST -
Survey of 25 Physicians: Gauging expectations for Sierra Oncology's MOMENTUM data read out for Momelotinib in Myelofibrosis
Tickers: SRRA, CTIC
Executed On: Jan 20, 2022 at 04:25 PM EST -
A Sixth Take: Looking at Momelotinib & Pacritinib in treating Myelofibrosis
Tickers: SRRA, CTIC
Executed On: Jan 20, 2022 at 10:10 AM EST -
A Fifth Take: Looking at Momelotinib & Pacritinib in treating Myelofibrosis
Tickers: SRRA, CTIC
Executed On: Jan 19, 2022 at 11:00 AM EST -
A Fourth Take: Looking at Momelotinib & Pacritinib in treating Myelofibrosis
Tickers: SRRA, CTIC
Executed On: Jan 17, 2022 at 05:00 PM EST -
A Third Take: Looking at Momelotinib & Pacritinib in treating Myelofibrosis
Tickers: SRRA, CTIC
Executed On: Jan 14, 2022 at 04:00 PM EST
Upcoming & Overdue Catalysts (CTIC)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (CTIC)
-
CTI BioPharma (CTIC) Gains Accelerated Approval Pathway for Pacritinib in Treating Myelofibrosis Patients With Severe Thrombocytopenia
Ticker: CTIC
Occurred on: Feb 03, 2020 -
CTI BioPharma Announces Top-Line Results From PERSIST-2 Phase 3 Trial Of Pacritinib For High-Risk Patients With Advanced Myelofibrosis
Ticker: CTIC
Occurred on: Aug 29, 2016 -
CTI Biopharma's IND for pacritinib has been placed on full clinical hold
Ticker: CTIC
Occurred on: Feb 09, 2016
Strategic Initiatives (CTIC)
-
Baxalta (SHPG) Pays $10.3MM to Return Blood Cancer Candidate Pacritinib to CTI BioPharma (CTIC)
Tickers: CTIC, SHPG, Baxalta
Announcement Date: Oct 24, 2016
